Viewing Study NCT04578756


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-02-01 @ 1:28 PM
Study NCT ID: NCT04578756
Status: COMPLETED
Last Update Posted: 2025-10-27
First Post: 2020-10-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Bipolar I Disorder View
None Autism Spectrum Disorder (ASD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None Bipolar I Disorder View
None Cariprazine View
None Autism Spectrum Disorder (ASD) View